Table 3.

Laboratory parameters in the SCCRIP BMD cohort

Variable	All (N = 306)		Female (n = 153)		Male (n = 153)
	Normal BMD (n = 250 [81.7%])	Low BMD (n = 56 [18.3%])	Normal BMD (n = 128 [83.7%])	Low BMD (n = 25 [16.3%])	Normal BMD (n = 122 [79.7%])	Low BMD (n = 31 [20.3%])
WBC, ×109/L	9.3 ± 4.03	9.6 ± 3.71	9.0 ± 3.92	9.5 ± 4.37	9.7 ± 4.13	9.6 ± 3.14
Hemoglobin, g/dL	10.2 ± 1.60*	9.5 ± 1.45*	10.0 ± 1.45	9.5 ± 1.31	10.3 ± 1.74*	9.5 ± 1.58*
Platelets, ×109/L	343.5 ± 174.97	383.0 ± 182.02	323.4 ± 158.85	388.0 ± 196.77	363.9 ± 188.42	378.8 ± 172.07
LDH, U/L	411.0 ± 177.51	420.9 ± 164.17	374.8 ± 149.96	369.9 ± 143.80	449.9 ± 196.30	461.6 ± 170.24
Total bilirubin, mg/dL	1.9 ± 1.28*	2.6 ± 1.62*	1.7 ± 1.09	2.4 ± 1.72	2.0 ± 1.44*	2.7 ± 1.55*
Indirect bilirubin, mg/dL	2.1 ± 1.21*	2.6 ± 1.48*	2.0 ± 0.96	2.6 ± 1.58	2.1 ± 1.41*	2.6 ± 1.44*
Fetal hemoglobin, %	15.3 ± 10.64	13.1 ± 7.82	15.0 ± 10.85	11.7 ± 7.64	15.6 ± 10.46	14.2 ± 7.95
Albumin, g/dL	4.4 ± 0.27	4.4 ± 0.31	4.4 ± 0.27	4.5 ± 0.25	4.5 ± 0.28	4.4 ± 0.35
ALP, U/L	158.4 ± 72.09	142.5 ± 59.77	140.4 ± 72.30	128.1 ± 62.48	176.4 ± 67.50	154.3 ± 55.81
AST/SGOT, U/L	34.8 ± 15.17	34.8 ± 12.29	32.1 ± 15.14	31.4 ± 11.22	37.5 ± 14.78	37.6 ± 12.62
Calcium, mg/dL	9.5 ± 0.37*	9.4 ± 0.31*	9.4 ± 0.38	9.4 ± 0.28	9.5 ± 0.35*	9.3 ± 0.34*
Creatinine, mg/dL	0.5 ± 0.16	0.5 ± 0.13	0.5 ± 0.15	0.5 ± 0.11	0.5 ± 0.18	0.5 ± 0.15
BUN, mg/dL	7.5 ± 2.67	7.0 ± 2.07	7.2 ± 2.16	6.7 ± 2.26	7.9 ± 3.08	7.1 ± 1.93
Vitamin D, ng/mL	25.0 ± 11.13	22.5 ± 8.35	24.8 ± 10.85*	19.6 ± 8.17*	25.3 ± 11.46	25.2 ± 7.70

Data are presented as mean ± standard deviation.

ALP, alkaline phosphatase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; SGOT, serum glutamic-oxaloacetic transaminase; WBC, white blood cell count.

^*P < .05 for normal vs low BMD values, per variable.